Cell-free tumor DNA, CA125 and HE4 for the objective assessment of tumor burden in patients with advanced high-grade serous ovarian cancer.

Autor: Heitz, Florian1,2,3,4 (AUTHOR) florian.heitz@gmx.net, Lakis, Sotirios5,6 (AUTHOR), Harter, Philipp1 (AUTHOR), Heikaus, Sebastian7 (AUTHOR), Sehouli, Jalid2,3,4 (AUTHOR), Talwar, Jatin5 (AUTHOR), Menon, Roopika5 (AUTHOR), Ataseven, Beyhan1,8 (AUTHOR), Bertrand, Miriam5,9 (AUTHOR), Schneider, Stephanie1 (AUTHOR), Mariotti, Erika5 (AUTHOR), Bommert, Mareike1 (AUTHOR), Müller, Judith N.5 (AUTHOR), Prader, Sonia1,10,11 (AUTHOR), Leenders, Frauke5 (AUTHOR), Hengsbach, Alexandra1 (AUTHOR), Gloeckner, Christian5 (AUTHOR), Braicu, Elena Ioana7 (AUTHOR), Heukamp, Lukas C.5 (AUTHOR), du Bois, Andreas1 (AUTHOR)
Zdroj: PLoS ONE. 2/7/2022, Vol. 17 Issue 2, p1-15. 15p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje